New Bioreactor-based approach to stem cell/progenitor expansion for cell therapie
Award amount
$828,355Program and phase
SBIR · Phase IIAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Synthecon, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Q89PFQ65RQT3
- Solicitation number
- PHS2010-2
- Topic code
- NICHD
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- SBIR Phase I: Agonist-mimetic Aptamers: a New Method to Control Stem Cell Fate
- New bioreactor-based approach to stem cell/progenitor expansion for cell therapie
- Methods for Improving Pancreatic Islet Transplantation
- Methods for Improving Pancreatic Islet Transplantation
- BIOREACTOR FOR STEM CELL TISSUE ENGINEERING
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Developing RNA therapeutics for rare neurodevelopmental disorders
- SPIRIT Club CBI Pathway: A novel streaming platform for physical activity and wellness promotion for chronic brain injury survivors
- Zip-stitch for Laparoscopic Hysterectomy - Clinical Validation
- Point-of-care Testing (POCT) Tool Development for Critical Oxytocin Measurement
- Novel, Non-hormonal Therapeutic for Endometriosis
Research funding history
7 SBIR/STTR records share this UEI (1996–2010). Reported award amounts total $2,007,926. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation, National Aeronautics and Space Administration